<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0000001'>All</z:hpo> hepatotropic viruses are known to cause <z:hpo ids='HP_0004448'>fulminant hepatic failure</z:hpo> (<z:chebi fb="0" ids="30480">FHF</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, in 30% to 40% of patients with <z:chebi fb="0" ids="30480">FHF</z:chebi>, the precise cause remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to better define this subgroup </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We evaluated the clinical course and outcome of 7 patients admitted during a 22-month period with fulminant <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> leading to liver transplantation; none had serologic or molecular evidence of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> A, B, C, D, E, or G <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, thus the term non-A-G <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> known etiologies of <z:chebi fb="0" ids="30480">FHF</z:chebi> were excluded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients had prodromal symptoms suggestive of <z:mp ids='MP_0001799'>viral</z:mp> causes </plain></SENT>
<SENT sid="6" pm="."><plain>Mean age was 30 years </plain></SENT>
<SENT sid="7" pm="."><plain>The interval between <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000952'>jaundice</z:hpo> and appearance of <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> was 23 days (range, 4-50 days) </plain></SENT>
<SENT sid="8" pm="."><plain>Five patients had grade III/IV <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Serum alanine aminotransferase levels showed a single peak of activity </plain></SENT>
<SENT sid="10" pm="."><plain>The duration between first symptoms and liver transplantation was 28 days (range, 12-71 days) </plain></SENT>
<SENT sid="11" pm="."><plain>Results of histological study of the explanted liver showed submassive (4 patients) or massive (3 patients) hepatocyte <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, results of polymerase chain reaction analysis did not detect <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus DNA, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus <z:chebi fb="40" ids="33697">RNA</z:chebi>, or <z:hpo ids='HP_0012115'>hepatitis</z:hpo> G virus <z:chebi fb="40" ids="33697">RNA</z:chebi> in the explanted liver </plain></SENT>
<SENT sid="13" pm="."><plain>After transplantation, 2 patients showed (6 months later) increased liver enzyme levels of undetermined cause, and results of a liver biopsy showed mild lobular <z:hpo ids='HP_0012115'>hepatitis</z:hpo>; 1 patient had <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (Epstein-Barr virus-originated); and 1 patient, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, which is known to be associated with seronegative <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>The latter patient died, whereas the other 6 patients are alive (survival rate, 86%) </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: Our patients with non-A-G <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> had a severe <z:hpo ids='HP_0011009'>acute onset</z:hpo> with progressive <z:chebi fb="0" ids="30480">FHF</z:chebi> requiring liver transplantation </plain></SENT>
<SENT sid="16" pm="."><plain>There is some suggestion of recurrent <z:mp ids='MP_0001799'>viral</z:mp> disease after transplantation implicating other unknown viruses in the etiology </plain></SENT>
</text></document>